Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications

Heterogeneity of anoikis in triple-negative breast cancer subtyping and therapeutic implications

Saved in:

Bibliographic Details
Main Authors:	Kun Fang, Suxiao Jiang, Zhengjie Xu, Meng Luo, Changsheng Yan
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-01-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304224000527
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Disulfidptosis heterogeneity in breast cancer uncovers PTTG1IP as an actionable therapeutic target
by: Kun Fang, et al.
Published: (2025-01-01)

Pan-cancer landscape of disulfidptosis across human tumors
by: Kun Fang, et al.
Published: (2024-11-01)

Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications
by: Xiaoxiao Wang, et al.
Published: (2024-11-01)

Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-03-01)

Intrinsic subtype and immunity score in identification of triple-negative breast cancer at low risk
by: Xinyu Ren, et al.
Published: (2025-04-01)

Correction: Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer
by: Shanqi Li, et al.
Published: (2024-12-01)

Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
by: Parvin F. Peddi, et al.
Published: (2012-01-01)

Classifications of triple-negative breast cancer: insights and current therapeutic approaches
by: Ziqi Chen, et al.
Published: (2025-02-01)

Predicting the Clinical Outcome of Triple-Negative Breast Cancer Based on the Gene Expression Characteristics of Necroptosis and Different Molecular Subtypes
by: Peng Luo, et al.
Published: (2023-01-01)

Characterization of Triple Negative Breast Cancer
by: Bernardo Enrique Heredia Martínez, et al.
Published: (2020-09-01)

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities
by: Wen-yu Cai, et al.
Published: (2025-02-01)

Investigation of survival and prognostic factors in triple negative molecular subtype male breast cancer patients: A population-based study
by: Ahmet Necati Sanli, et al.
Published: (2024-04-01)

Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic Mechanisms
by: Zhengjie Shen, et al.
Published: (2022-01-01)

Apigenin is an anoikis sensitizer with strong anti-metastatic properties in experimental breast cancer
by: Ruijie Xu, et al.
Published: (2024-07-01)

Protein arginine methyltransferase 5: A novel therapeutic target for triple‐negative breast cancers
by: Mathilde Vinet, et al.
Published: (2019-05-01)

Integrative analysis of anoikis-related prognostic signature to evaluate the immune landscape and predict therapeutic response in stomach adenocarcinoma
by: Ziyi Zhou, et al.
Published: (2025-02-01)

Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
by: Desh Deepak Singh, et al.
Published: (2024-12-01)

Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
by: Lucía Serrano García, et al.
Published: (2024-12-01)

Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis
by: Qi Xu, et al.
Published: (2024-10-01)

Machine learning based anoikis signature predicts personalized treatment strategy of breast cancer
by: Xiao Guo, et al.
Published: (2024-11-01)

Comprehensive Analysis of the Mechanism of Anoikis in Hepatocellular Carcinoma
by: Dongqian Li, et al.
Published: (2024-01-01)

Unveiling the Mechanisms and Therapeutic Effects of Xiaoyao Sanjie Decoction in Triple-Negative Breast Cancer: A Network Pharmacology and Experimental Validation Approach
by: Qi Y, et al.
Published: (2024-12-01)

Tumor microenvironment and immunotherapy for triple-negative breast cancer
by: Zijie Guo, et al.
Published: (2024-12-01)

Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
by: Yuhan Liu, et al.
Published: (2024-11-01)

Clinical Characteristics in Patients with Triple Negative Breast Cancer
by: Janet Yeh, et al.
Published: (2017-01-01)

Natural products as part of triple negative breast cancer
by: Yozlem Kobakova, et al.
Published: (2025-01-01)

Triple-Negative Breast Cancer: Tumor Immunogenicity and Beyond
by: Elio Ibrahim, et al.
Published: (2024-01-01)

Triple-negative ectopic breast cancer of the male scrotum: a case report
by: Yuhui Nie, et al.
Published: (2024-12-01)

Endothelial Cells Potentially Participate in the Metastasis of Triple-Negative Breast Cancer
by: Yanfei Ma, et al.
Published: (2022-01-01)

The overview of modern approaches in treatment of triple negative breast cancer
by: A. A. Kharitonova, et al.
Published: (2020-03-01)

Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer
by: Morgane Fournier, et al.
Published: (2024-10-01)

The analysis of gene co-expression network and immune infiltration revealed biomarkers between triple-negative and non-triple negative breast cancer
by: Yao Yi, et al.
Published: (2025-01-01)

Network pharmacological analysis and in vitro testing of the rutin effects on triple-negative breast cancer
by: Chang Cheng, et al.
Published: (2025-01-01)

DLAT promotes triple-negative breast cancer progression via YAP1 activation
by: Diya Liu, et al.
Published: (2024-12-01)

Ketogenesis promotes triple-negative breast cancer metastasis via calpastatin β-hydroxybutyrylation
by: Haoran Jiang, et al.
Published: (2024-11-01)

Targeting PRMT5 through PROTAC for the treatment of triple-negative breast cancer
by: Yaxun Guo, et al.
Published: (2024-11-01)

Unlocking the epigenetic code: new insights into triple-negative breast cancer
by: Gowthami Mahendran, et al.
Published: (2024-12-01)

Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
by: Soo Young Cho
Published: (2019-03-01)

Outcome for Patients with Triple-Negative Breast Cancer Is Not Dependent on Race/Ethnicity
by: Quyen D. Chu, et al.
Published: (2012-01-01)

Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm
by: Andrew A. Davis, et al.
Published: (2012-01-01)